Key result
Review highlights leptin physiology, cardiometabolic disease mechanisms, and emerging clinical roles for leptin analogs.
Why the study?
Leptin's role in metabolism and cardiometabolic diseases has been extensively studied in animals but less so in humans, necessitating a comprehensive review.
This review summarizes the physiology of leptin and its role in metabolism and cardiometabolic diseases, discussing clinical applications and future research directions.
Leptin has emerged over the past 2 decades as a key hormone secreted by adipose tissue that conveys information on energy stores. Leptin is considered an important regulator of both neuroendocrine function and energy homeostasis. Numerous studies (mainly preclinical and much less in humans) have investigated the mechanisms of leptin's actions both in the healthy state as well as in a wide range of metabolic diseases. In this review, the authors present leptin physiology and review the main findings from animal studies, observational and interventional studies, and clinical trials in humans that have investigated the role of leptin in metabolism and cardiometabolic diseases (energy deficiency, obesity, diabetes, cardiovascular diseases, nonalcoholic fatty liver disease). The authors discuss the similarities and discrepancies between animal and human biology and present clinical applications of leptin, directions for future research, and current approaches for the development of the next-generation leptin analogs.
No takes yet. Share an insight, caveat, or question.
Perakakis et al. (2021) conducted a review in Cardiometabolic diseases (obesity, diabetes, cardiovascular diseases). Leptin was evaluated. This review summarizes leptin physiology and its role in metabolism and cardiometabolic diseases, discussing clinical applications and future directions for leptin analogs.
Synapse has enriched 5 related papers. Consider them for comparative context: